Thanks to you and I dunno for your informative replies.
This conference in early December sounds like a possible venue to provide more detailed trial results, after providing the quick live abstract version at SNO!!
These events are 2-3 weeks apart.
These reporting opportunities could likely be preceded by an NWBO PR giving TLD met or didn’t meet results, setting up great anticipation for the SNO and GBM drug development events. Sounds plausible ?